Showing results (1-10 of 286) with videos related to
Sort By:
Pageof 29
Expert Opinion on Investigational Drugs|April 28, 2007
Tafenoquine: a promising new antimalarial agentMaryanne Crockett, Kevin C KainMicrobes and Infection|June 15, 2010
Malaria exacerbates experimental mycobacterial infection in vitro and in vivoMichael Hawkes, Xiaoming Li, Maryanne Crockett, et al.Paediatrics & Child Health|August 12, 2009
New faces from faraway places: Immigrant child health in CanadaMaryanne CrockettThe New England Journal of Medicine|April 19, 2008
Pyruvate kinase deficiency and malariaKodjo Ayi, Gundula Min-Oo, Lena Serghides, et al.BMC Infectious Diseases|October 19, 2010
CD36 deficiency attenuates experimental mycobacterial infectionMichael Hawkes, Xiaoming Li, Maryanne Crockett, et al.Journal of Travel Medicine|October 18, 2005
"I hate needles" and other factors impacting on travel vaccine uptakeMaryanne Crockett, Jay KeystoneBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 6, 2003
Current status and replies to frequently posed questions on atovaquone plus proguanil (Malarone) for the prevention of malariaKevin C KainJournal of Travel Medicine|May 10, 2003
Atovaquone/proguanil: the need for family protectionKevin C KainInfection and Immunity|January 25, 2005
Peroxisome proliferator-activated receptor gamma and retinoid X receptor agonists have minimal effects on the interaction of endothelial cells with Plasmodium falciparum-infected erythrocytesLena Serghides, Kevin C KainLancet (London, England)|April 30, 2002
Mechanism of protection induced by vitamin A in falciparum malariaLena Serghides, Kevin C KainPageof 29